Alteron Therapeutics Revenue

Pharmaceutical Manufacturing • Kalamazoo, Michigan, United States • 1-10 Employees

Alteron Therapeutics revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Alteron Therapeutics

Chengliang Zhang

Co-Founder

Company overview

Headquarters	4717 Campus Dr, Kalamazoo, Michigan 49008, US
Websites	alterontherapeutics.com alterontx.com
NAICS	3254
Founded	2017
Employees	1-10
Socials

About Alteron Therapeutics

Alteron Therapeutics is a biotech startup dedicated to developing innovative drugs for the treatment Alzheimer's disease (AD) and Amyotrophic Lateral Sclerosis (ALS). We target high TDP-43 activity, which is the root cause of neuronal death. By inhibiting TDP-43, out drugs can simultaneously eliminate the three pathological markers of neurodegeneration and their efficacy has been verified in an hTDP-43 transgenic mouse disease model.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Alteron Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Alteron Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-09-01	3	N/A

Funding Insights

Number of funding rounds

Alteron Therapeutics Tech Stack

Discover the technologies and tools that power Alteron Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

Open Graph

Miscellaneous

Webflow

Page builders

core-js

JavaScript libraries

Frequently asked questions

Alteron Therapeutics is located in Kalamazoo, Michigan, US.

Alteron Therapeutics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Alteron Therapeutics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Alteron Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Alteron Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Alteron Therapeutics

Chengliang Zhang

Co-Founder

4.8

40,000 users